These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24702987)

  • 1. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
    Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Vanderhasselt MA; Nitsche MA; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis.
    Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():91-6. PubMed ID: 25172025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
    Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
    J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial.
    Brunoni AR; Machado-Vieira R; Zarate CA; Valiengo L; Vieira EL; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Psychopharmacology (Berl); 2014 Apr; 231(7):1315-23. PubMed ID: 24150249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial.
    Brunoni AR; Machado-Vieira R; Sampaio-Junior B; Vieira EL; Valiengo L; Benseñor IM; Lotufo PA; Carvalho AF; Cho HJ; Gattaz WF; Teixeira AL
    J Affect Disord; 2015 Oct; 185():209-13. PubMed ID: 26241865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in PAS-induced neuroplasticity after a treatment course of transcranial direct current stimulation for depression.
    Player MJ; Taylor JL; Weickert CS; Alonzo A; Sachdev PS; Martin D; Mitchell PB; Loo CK
    J Affect Disord; 2014; 167():140-7. PubMed ID: 24968188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial direct current stimulation of 20- and 30-minutes combined with sertraline for the treatment of depression.
    Pavlova EL; Menshikova AA; Semenov RV; Bocharnikova EN; Gotovtseva GN; Druzhkova TA; Gersamia AG; Gudkova AA; Guekht AB
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():31-38. PubMed ID: 29233783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial.
    Brunoni AR; Valiengo L; Baccaro A; Zanão TA; de Oliveira JF; Goulart A; Boggio PS; Lotufo PA; Benseñor IM; Fregni F
    JAMA Psychiatry; 2013 Apr; 70(4):383-91. PubMed ID: 23389323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
    Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
    Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression.
    Brunoni AR; Padberg F; Vieira ELM; Teixeira AL; Carvalho AF; Lotufo PA; Gattaz WF; Benseñor IM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():211-217. PubMed ID: 29894705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases.
    Valiengo L; Benseñor IM; Goulart AC; de Oliveira JF; Zanao TA; Boggio PS; Lotufo PA; Fregni F; Brunoni AR
    Depress Anxiety; 2013 Jul; 30(7):646-53. PubMed ID: 23625554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of blinding effectiveness between sham tDCS and placebo sertraline in a 6-week major depression randomized clinical trial.
    Brunoni AR; Schestatsky P; Lotufo PA; Benseñor IM; Fregni F
    Clin Neurophysiol; 2014 Feb; 125(2):298-305. PubMed ID: 23994192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive effects of transcranial direct current stimulation in depression: Results from the SELECT-TDCS trial and insights for further clinical trials.
    Brunoni AR; Tortella G; Benseñor IM; Lotufo PA; Carvalho AF; Fregni F
    J Affect Disord; 2016 Sep; 202():46-52. PubMed ID: 27253216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
    Gorgulu Y; Caliyurt O
    Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
    Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH;
    Brain Stimul; 2018; 11(1):125-133. PubMed ID: 29111077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
    Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
    J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives.
    Brunoni AR; Valiengo L; Baccaro A; Zanao TA; de Oliveira JF; Vieira GP; Bueno VF; Goulart AC; Boggio PS; Lotufo PA; Bensenor IM; Fregni F
    Contemp Clin Trials; 2011 Jan; 32(1):90-8. PubMed ID: 20854930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study.
    Brunoni AR; Kemp AH; Dantas EM; Goulart AC; Nunes MA; Boggio PS; Mill JG; Lotufo PA; Fregni F; Benseñor IM
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1937-49. PubMed ID: 23759172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.